Navigation Links
Combined Sales of Seven Emerging Therapies for Breast Cancer, Including Drugs From Sanofi-Aventis and AstraZeneca, Will Total Nearly $5 Billion by 2019
Date:10/27/2010

irmed its existing recommendation for Avastin is a positive sign for Roche. However, even in the event that Avastin manages to hang on to a first-line metastatic breast cancer label it's sales -- which surpassed $1 billion for breast cancer alone in 2009 in the world's major markets -- will plummet over the next several years," said Decision Resources Analyst Niamh Murphy, Ph.D. "By 2019, sales of Avastin in breast cancer will drop to $350 million as a result of oncologists' diminishing confidence in the agent, increased prescribing and reimbursement restrictions and competition from emerging therapies -- most notably, iniparib and Eli Lilly's VEGF inhibitor, ramucirumab."

About Pharmacor 2010The newly redesigned Pharmacor advisory service offers clients in the biopharmaceutical industry the most up-to-date information available on commercially significant disease topics.

About Decision ResourcesDecision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or

registered trademarks of their respective holders.For more information, contact:Decision Resources, Inc.Christopher Comfort781-993-2597 ccomfort@dresources.com
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity
2. FDA Issues Complete Response Letter For Trabectedin Combined With DOXIL
3. Nanoelectronic transistor combined with biological machine could lead to better electronics
4. First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter
5. Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors
6. SuperGens MP-470 Demonstrates Clinical Tumor Regression When Combined with Standard of Care Chemotherapy
7. Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 -
8. Microbix Has Best-Ever Quarterly Sales
9. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
10. Immune Biosimilars Will Erode $10.8 Billion in Immune Biologics Brand Sales in 2019 Across the U.S., EU5 and Japan
11. Dynamic Ventures Corporation enters into a long-term agreement that brings $50 million annual sales opportunity for wholly owned subsidiary EZ-Build.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 Follow us ... steady popularity the world over, due to its ... in the marketplace is expected to come from ... developing countries. Several sub-Saharan countries in the African ... already implemented genetically engineered crop production strategies. Rising ...
(Date:9/23/2014)... , Sept. 23, 2014  Age Defying Dermatology ® ... , has become one of the first clinics in ... "picoseconds" aesthetic laser for tattoo removal. The treatment safely ... results. "For years, tattoo removal has been a lengthy, ... Noodleman. "This is an opportunity to erase tattoo pigment ...
(Date:9/23/2014)... - Portage Biotech Inc. ("Portage" or "the Company") (OTC: ... announce that its wholly owned subsidiary, Portage Pharmaceuticals ... its team for further development of its PPL-003 ... permeable peptide platform technology derived from human genes ... Ms. Holly Prentice ...
(Date:9/23/2014)... BOSTON, Mass. (PRWEB) September 23, 2014 ... driven by Semantic Web technology, was named in the ... by Gartner, Inc. , The report details key ... category. , According to Gartner analysts Michael Shanler ... help accelerate innovation activities, expose complex relationships with scientific ...
Breaking Biology Technology:Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Rising Focus on Food Security Spurs Growth in the Global Agricultural Biotechnology Market, According to New Report by Global Industry Analysts, Inc. 4Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2Portage Announces New Consultants for its PPL-003 Development Programs 2Portage Announces New Consultants for its PPL-003 Development Programs 3Portage Announces New Consultants for its PPL-003 Development Programs 4Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2
... 17 PLC Systems Inc.,(AMEX: PLC ) today ... the,American Stock Exchange that would demonstrate its ability to ... that its common stock will be delisted from the ... to trade on the,over-the-counter bulletin board., As previously ...
... DNA2.0, the leading synthetic genomics company, announced today a significant ... interface, a customer-friendly site navigation, a database of published synthetic ... with a powerful resource for analyzing DNA and protein sequences. ... ...
... 17 Waters Corporation,(NYSE: WAT ) ... detection of melamine in,infant formula and liquid ... of Science and Technology (M.O.S.T.). The new ... with tandem,quadrupole mass spectrometry (UPLC/MS/MS) operated in ...
Cached Biology Technology:PLC Systems Expects Common Stock To Be Delisted From American Stock Exchange 2PLC Systems Expects Common Stock To Be Delisted From American Stock Exchange 3DNA2.0 Launches New Website: Enhanced Design and Free Bioinformatics Tools Demonstrate DNA2.0's Customer Focus 2Waters Publishes Rapid and Specific Method of Detection for Melamine in Infant Formula and Liquid Milk, in Support of China's Ministry of Science and Technology 2
(Date:9/23/2014)... Health will award funds to support the next phase ... improve ways of predicting drug safety and effectiveness. Researchers ... human tissue chips and combine them into an integrated ... human body. Led by the National Center for Advancing ... at $17 million in 2014 with additional support over ...
(Date:9/23/2014)... Foundation scientists have published a study showing that ... task-specific movement for 4 weeks can retrain the ... foot drop stimulator as rehabilitation intervention may facilitate ... of the tibialis anterior demonstrates a training effect ... published online ahead of print on July 2 ...
(Date:9/23/2014)... cow rumens and termite guts for microbes that can ... of next-generation biofuels, but some of the best microbial ... researchers report. , Their study , reported in ... , is the first to use biochemical approaches to ... can digest fiber, breaking it down into simple sugars ...
Breaking Biology News(10 mins):NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3
... announces that a new market research report is available ... Industry http://www.reportlinker.com/p090669/Global-Flow-Cytometers-Industry.html ... in US$ Million. The report provides separate comprehensive analytics ... America. Annual estimates and forecasts are provided for the ...
... eye disorder characterized by progressive loss of vision that ... end stage. , In a ChIP-Seq based approach, the ... factor Crx (Cone-rod homeobox) in the expression of retina-specific ... visual perception. In-depth analysis of Crx mediated regulation in ...
... The 2010 Golf Atlanta charity golf tournament raised $105,000 in ... treatments and eventually a cure for pancreatic cancer. 2010 ... Crabapple Golf Club in Alpharetta, Ga., just north of Atlanta. ... a non-profit biomedical research facility in Phoenix, Ariz., working to ...
Cached Biology News:Reportlinker Adds Global Flow Cytometers Industry 2Reportlinker Adds Global Flow Cytometers Industry 3Reportlinker Adds Global Flow Cytometers Industry 4Reportlinker Adds Global Flow Cytometers Industry 5Reportlinker Adds Global Flow Cytometers Industry 6Reportlinker Adds Global Flow Cytometers Industry 7Reportlinker Adds Global Flow Cytometers Industry 8Reportlinker Adds Global Flow Cytometers Industry 9Transcription factor scan identifies genetic cause for inherited blindness 2Golf Atlanta charity tournament raises $105,000 for TGen research 2